Short Description Blueprint Medicines develops selective kinase inhibitors to support healthy longevity.
Description Blueprint Medicines is a biotechnology innovator targeting the fundamental mechanisms of aging through selective kinase inhibitors. The company leverages advancements in precision oncology and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Blueprint Medicines aims to extend healthspan and improve quality of life across the globe.
Address 45 Sidney St, Cambridge, MA, USA